Brandywine Managers, LLC Regenxbio Inc. Transaction History

Brandywine Managers, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $223,974 - $279,312	-6,900 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $10,083 - $14,985	300 Added 4.55%	6,900 $235,000
Q4 2020 Feb 12, 2021	BUY	$26.52 - $49.35 $175,032 - $325,710	6,600 New	6,600 $299,000
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $167,462 - $249,612	-6,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $8,600 - $21,680	400 Added 6.9%	6,200 $201,000

Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $9,552 - $15,264	300 Added 5.45%	5,800 $206,000
Q2 2019 Aug 13, 2019	BUY	$42.0 - $59.29 $25,200 - $35,574	600 Added 12.24%	5,500 $283,000
Q1 2019 May 14, 2019	SELL	$40.82 - $62.45 $28,574 - $43,715	-700 Reduced 12.5%	4,900 $281,000
Q4 2018 Feb 12, 2019	BUY	$39.11 - $75.15 $219,016 - $420,840	5,600 New	5,600 $235,000

192

42.6M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $590M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Brandywine Managers, LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Managers, LLC with notifications on news.